SCHEMBL4604562

SCHEMBL4604562

CCC(=O)Nc1ccc(Br)cc1C(=O)OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
GAA P10253 2/20 0.60
POLB P06746 3/20 0.55
KMT2A Q03164 2/20 0.50
HTT P42858 1/20 0.50
KDM4E B2RXH2 4/20 0.49
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
PSMD14 O00487 1/20 0.47
MMP2 P08253 1/20 0.47
DNMT1 P26358 1/20 0.47
RECQL P46063 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.47
GPR35 Q9HC97 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29441245 1.00 ALDH1A1 (0.60) ALDH1A1GAAPOLBKMT2AHTT
SCHEMBL16650906 0.88 ALDH1A1 (0.60) ALDH1A1GAAPOLBKMT2AHTT
SCHEMBL24373505 0.88 KDM4E (0.54) ALDH1A1GAAPOLBKMT2AHTT
SCHEMBL7929900 0.87 ALDH1A1 (0.59) ALDH1A1GAAPOLBKMT2AHTT
SCHEMBL8715955 0.86 POLB (0.76) ALDH1A1GAAPOLBKMT2AKDM4E
SCHEMBL4604248 0.84 CA12 (0.57) ALDH1A1GAAKMT2AHTTKDM4E
SCHEMBL28327811 0.84 HPGD (0.58) ALDH1A1GAAPOLBKMT2AKDM4E
SCHEMBL4605157 0.83 L3MBTL1 (0.55) ALDH1A1POLBKMT2AHTTKDM4E
SCHEMBL3457070 0.83 ALDH1A1 (0.67) ALDH1A1GAAPOLBKMT2AKDM4E
SCHEMBL5899451 0.83 ALDH1A1 (0.67) ALDH1A1GAAPOLBHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220227720-A1 DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS AIX-MARSEILLE UNIVERSITE (FR) 2022-07-21 US disclosed
EP-3965753-A1 DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS Universität Hamburg (DE) 2022-03-16 EP disclosed
WO-2020225330-A1 DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS UNIVERSITÄT HAMBURG (DE) 2020-11-12 WO disclosed
WO-2020225330-A1 DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS UNIVERSITÄT HAMBURG (DE) 2020-11-12 WO disclosed
EP-1720825-B1 ANTHRANILIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE AS DHODH INHIBITORS ACTIVE BIOTECH AB (SE) 2008-07-09 EP disclosed
EP-1720825-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Active Biotech AB (SE) 2006-11-15 EP disclosed
US-7074831-B2 Compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2006-07-11 US disclosed
US-20050187297-A1 New compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2005-08-25 US disclosed
WO-2005075410-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF ACTIVE BIOTECH AB (SE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220227720-A1 DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS DHODH, DHX15, DHX29 ALDH1A1 392/4885GAA 498/4885POLB 448/4885
US-20050187297-A1 New compounds, methods for their preparation and use thereof MALT1, TPMT, FUCA1 ALDH1A1 308/4885GAA 864/4885POLB 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.